
Merck KGaA
XETRA:MRK

Intrinsic Value
The intrinsic value of one
MRK
stock under the Base Case scenario is
158.64
EUR.
Compared to the current market price of 126.25 EUR,
Merck KGaA
is
Undervalued by 20%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Merck KGaA
Fundamental Analysis


Revenue & Expenses Breakdown
Merck KGaA
Balance Sheet Decomposition
Merck KGaA
Current Assets | 13.5B |
Cash & Short-Term Investments | 3.2B |
Receivables | 4.6B |
Other Current Assets | 5.7B |
Non-Current Assets | 38.1B |
Long-Term Investments | 1.2B |
PP&E | 10B |
Intangibles | 25.4B |
Other Non-Current Assets | 1.5B |
Free Cash Flow Analysis
Merck KGaA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Merck KGaA
Revenue
|
21.2B
EUR
|
Cost of Revenue
|
-8.6B
EUR
|
Gross Profit
|
12.6B
EUR
|
Operating Expenses
|
-8.2B
EUR
|
Operating Income
|
4.4B
EUR
|
Other Expenses
|
-1.6B
EUR
|
Net Income
|
2.8B
EUR
|
MRK Profitability Score
Profitability Due Diligence
Merck KGaA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Score
Merck KGaA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
MRK Solvency Score
Solvency Due Diligence
Merck KGaA's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
Merck KGaA's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MRK Price Targets Summary
Merck KGaA
According to Wall Street analysts, the average 1-year price target for
MRK
is 172.02 EUR
with a low forecast of 108.07 EUR and a high forecast of 208.95 EUR.
Dividends
Current shareholder yield for MRK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MRK
stock under the Base Case scenario is
158.64
EUR.
Compared to the current market price of 126.25 EUR,
Merck KGaA
is
Undervalued by 20%.